Fol. Biol. 2006, 52, 47-58
https://doi.org/10.14712/fb2006052030047
Immunological Profiles of Patients with Chronic Myeloid Leukaemia. I. State before the Start of Treatment
Crossref Cited-by Linking
- Cheung Darin, Hassan Mohammad Ali, Huynh Tri, Feng Xiaodong, Wang Hongbin: Shedding light on the role of complement C4 activation in cancer. Human Immunology 2025, 86, 111226. <https://doi.org/10.1016/j.humimm.2024.111226>
- Rohon Peter: Biological therapy and the immune system in patients with chronic myeloid leukemia. Int J Hematol 2012, 96, 1. <https://doi.org/10.1007/s12185-012-1116-8>
- Humlová Zuzana, Klamová Hana, Janatková Ivana, Malí\u010dková Karin, Králíková Petra, \u0160terzl Ivan, Roth Zden\u011bk, Ham\u0161íková Eva, Vonka Vladimír, Berzins Stuart: Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment. Journal of Immunology Research 2010, 2010. <https://doi.org/10.1155/2010/137320>
- Pavl\u016f Ji\u0159í, Kew Andrea K., Taylor-Roberts Beatrice, Auner Holger W., Marin David, Olavarria Eduardo, Kanfer Edward J., MacDonald Donald H., Milojkovic Dragana, Rahemtulla Amin, Rezvani Katayoun, Goldman John M., Apperley Jane F., Szydlo Richard M.: Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase. Blood 2010, 115, 4018. <https://doi.org/10.1182/blood-2010-01-263624>
- Vonka Vladimír: Immunotherapy of Chronic Myeloid Leukemia: Present State and Future Prospects. Immunotherapy 2010, 2, 227. <https://doi.org/10.2217/imt.10.2>